ClinicalTrials.govpublic full text
A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia
peritoneal dialysis chronic kidney disease patients with anemia, peritoneal dialysis, roxadustat, renal anemia, asp1517, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008000
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.